Ermelinda De Maio Selected Research

Ermelinda De Maio Research Topics

Disease

14	Breast Neoplasms (Breast Cancer) 08/2023 - 01/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2009 - 09/2004
4	Neoplasms (Cancer) 04/2009 - 12/2005
4	Hepatocellular Carcinoma (Hepatoma) 03/2008 - 06/2003
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2012 - 04/2009
2	Lung Neoplasms (Lung Cancer) 04/2009 - 10/2005
2	Carcinogenesis 03/2008 - 11/2006
2	Colorectal Neoplasms (Colorectal Cancer) 07/2006 - 03/2003
2	Carcinoma (Carcinomatosis) 02/2002 - 01/2002
1	Cardiotoxicity 09/2009
1	Multiple Myeloma 04/2009
1	Constipation 05/2008
1	Mucositis 05/2008
1	Dysgeusia (Parageusia) 05/2008
1	Abdominal Pain (Pain, Abdominal) 05/2008
1	Nausea 05/2008
1	Vomiting 05/2008
1	Renal Insufficiency (Renal Failure) 03/2007
1	Liver Neoplasms (Liver Cancer) 09/2006
1	Kidney Neoplasms (Kidney Cancer) 07/2006
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2006
1	Hypersensitivity (Allergy) 12/2005
1	Inflammatory Breast Neoplasms 02/2002

Drug/Important Bio-Agent (IBA)

6	Tamoxifen FDA LinkGeneric 01/2019 - 12/2005
4	Docetaxel (Taxotere)FDA Link 02/2011 - 02/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2023 - 03/2005
3	Hormones (Hormone)IBA 01/2019 - 03/2008
3	Letrozole (Femara)FDA LinkGeneric 01/2019 - 01/2008
3	Gemcitabine FDA Link 01/2012 - 09/2004
3	Fluorouracil (Carac)FDA LinkGeneric 05/2008 - 03/2003
3	Estrogens (Estrogen)FDA Link 03/2008 - 12/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2023 - 03/2022
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2022 - 04/2009
2	Triptorelin Pamoate (Trelstar)FDA Link 01/2019 - 01/2008
2	Trastuzumab (Herceptin)FDA Link 09/2009 - 03/2007
2	vandetanib (ZD6474)IBA 04/2009 - 07/2006
2	Methotrexate (Mexate)FDA LinkGeneric 05/2008 - 03/2005
2	Sorafenib (BAY 43-9006)FDA Link 03/2008 - 07/2006
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2008 - 11/2006
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2007 - 09/2004
1	liposomal doxorubicin (Doxil)FDA Link 08/2023
1	Interleukin-8 (Interleukin 8)IBA 03/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022
1	Thrombospondin 1IBA 03/2022
1	Bevacizumab (Avastin)FDA Link 03/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2009
1	Pemetrexed (MTA)FDA Link 04/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2009
1	Gefitinib (Iressa)FDA Link 04/2009
1	Tyrosine Kinase InhibitorsIBA 03/2008
1	AnthracyclinesIBA 03/2007
1	Pamidronate (Aredia)FDA LinkGeneric 03/2007
1	Taxoids (Taxanes)IBA 03/2007
1	Sunitinib (Sutent)FDA Link 07/2006
1	vatalanib (PTK787)IBA 07/2006
1	Aromatase InhibitorsIBA 12/2005
1	Fulvestrant (Faslodex)FDA Link 12/2005
1	Estrogen Receptor alphaIBA 12/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2005
1	Leucovorin (Folinic Acid)FDA Link 03/2003
1	Epirubicin (Ellence)FDA LinkGeneric 02/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2012 - 01/2002
3	Adjuvant Chemotherapy 05/2008 - 01/2002
2	Therapeutics 07/2006 - 12/2005
1	Surgical Instruments (Clip) 09/2006
1	Activities of Daily Living (ADL) 10/2005
1	Contraindications 06/2003
1	Neoadjuvant Therapy 02/2002
1	Combination Drug Therapy (Combination Chemotherapy) 01/2002